Clinical trials recruiting for Metastatic Triple Negative Breast Cancers
Fewer than 3 recruiting trials found.
2
Recruiting trials
1
US states with sites
2
Countries
50%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Non-Investigational Antibody-Drug Conjugates (ADC) | 1 |
| Selinexor | 1 |
| Talazoparib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
Top cities
Self-screener
Recruiting trials
- Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer
- Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
Related conditions
Trials recruiting for Metastatic Triple Negative Breast Cancers often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Metastatic Triple-Negative Breast Carcinoma 18Metastatic breast cancer 131HR+ HER2 Breast Cancer 17HER2 Negative Breast Carcinoma 15HER2-negative Breast Cancer 57
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Triple Negative Breast Cancers trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.